Chronos Archive seal

Review checklist: Wilma Mankiller (HR-ML052)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the slow prednisone rise, azathioprine after TPMT and infection screening, Pneumocystis prophylaxis, early robotic thymectomy at 34 with AChR antibodies and no thymoma, newer targeted therapies held in reserve, the missed early azathioprine blood tests, the ADPKD staging (Mayo 1B, so no tolvaptan) and the decision not to start a blood pressure medicine at normal-high readings.
provenance reviewnot_startedRecent-death rule: only what she made public and what obituaries and reference works reported: the Oklahoma Historical Society, the National Women's History Museum, the Encyclopedia of the Great Plains, the Oklahoma Hall of Fame, Encyclopedia.com, News On 6 (2000) and the Cherokee Phoenix (2010). Her autobiography and the New York Times obituary were not read directly.
safe messaging reviewnot_startedHer husband, daughters, brother and the friend killed in the crash are not named and are given no statement, decision or health fact. The emotional trauma of the crash is recorded as published, marked sensitive, with no diagnosis. Her Cherokee identity and medicine are described without stereotype and without describing any practice.

Judgment calls (dossier editorial resolutions)

  1. Sources. The history rests on the Oklahoma Historical Society encyclopedia, the National Women's History Museum, the Encyclopedia of the Great Plains, the Oklahoma Hall of Fame, Encyclopedia.com, News On 6 (2000), The Daily Beast's summary of the AP obituary, and two Cherokee Phoenix reports (2010). Her autobiography Mankiller: A Chief and Her People was not read directly and is cited only as quoted by the Oklahoma Historical Society. The New York Times obituary (paywalled; a reprint site returned an error) and the Cherokee Nation biography page (its text did not load) were not used. Wikipedia was not used.
  2. Recent-death rule. She died in 2010, so the rule applies. The record uses only what she made public and what obituaries and reference works reported. No sick visit is added. The emotional trauma after the crash (CLM-0006) is marked sensitive and recorded only as published; no mental health diagnosis is made, and the modern mood screens are synthetic and below the threshold for a safety assessment. Nothing in the modern episode adds an illness beyond those documented: blood pressure is kept normal-high without a hypertension diagnosis, and kidney function and urine albumin are normal.
  3. Living people and relatives. Her husband, daughters and brother are not named, and none is given a statement, decision or health fact; the kidney donor appears only as “her brother” in the documented claim. Her parents are named in the sources but not here. The friend killed in the crash, named in a source, is not named here. Living public figures named in the sources (a friend at her funeral, her predecessor as chief, officials) are not named. Her daughters appear in the modern episode only as members of her household, with no role in her care; her health care agent is unnamed. No other figure with a record is named, so identity.historical_mentions is not used. The word in one source about her mother's ancestry is not used, because it matches another record's alias.
  4. Name and alias. The alias is her full name, Wilma Pearl Mankiller (Oklahoma Historical Society), which appears in no other record. The display name splits simply, so identity.name_parts is not used. The notes call her Ms. Mankiller.
  5. Conflicts recorded. The crash is dated 1979 in most sources and 1978 by the Oklahoma Hall of Fame; 1979 is used. Her birthplace is Tahlequah in most sources (W.W. Hastings Indian Hospital in a Cherokee Nation release) and Rock Mountain in Adair County in the Hall of Fame; Tahlequah is used. The move to San Francisco is 1956 or 1957, and her return to Oklahoma 1976 or 1977. Lymphoma treatment is dated 1996 by News On 6, while the Great Plains encyclopedia links lymphatic cancer treatment and a second kidney operation to her 1995 decision not to run again. The Daily Beast gives her term as 1985 to 1996; the Oklahoma Historical Society gives 1995, which is used.
  6. Corrections to the brief. (1) The brief asked whether a thymectomy was documented. The sources say surgery helped her recovery from myasthenia gravis but do not name the operation, so no historical thymectomy is recorded; the modern episode's thymectomy is synthetic. (2) The brief gave the death as at her home in Adair County; the Cherokee Phoenix confirms “her home in rural Adair County.” (3) Breast cancer is dated 1999 only through a February 2000 article saying “last year.” (4) The polycystic kidney disease is described in the sources as hereditary; the autosomal dominant (adult) type, Q61.2, is an inference recorded in the claim.
  7. Index age and dates. The index visit on March 9, 2026 maps to March 9, 1980, when she was 34, in the year that one source dates her myasthenia gravis and less than a year after the 1979 crash (the month of the crash is not recorded). The synthetic date of birth is November 18, 1991, a shift of 46 years. The visits on March 23, May 4, July 13, August 24 and October 12, 2026, and the synthetic thymectomy on June 8, map to the same days of 1980, before her 35th birthday; she returned to work in 1981. The presenting pattern is used: ptosis, diplopia and fatigable weakness are a resolved problem (H53.2) at the second visit, when antibodies and nerve stimulation establish generalized MG (G70.00). The intake documents show only that MG is suspected; the claim about her diagnosis is linked to the 1981 return to work, so the intake H&P does not show it.
  8. Treatment choices. (1) Pyridostigmine 30 mg three times daily as a trial at intake, 60 mg four times daily at diagnosis, three times daily at seven months. (2) Prednisone started at 10 mg and raised weekly to 40 mg to avoid early worsening, held through thymectomy, then tapered by 5 mg every two to three weeks. (3) Azathioprine rather than mycophenolate because she is of childbearing age, after TPMT activity and hepatitis B and tuberculosis screening (results recorded in the notes, not as coded observations). (4) Early robotic extended thymectomy at 34 for AChR antibody-positive generalized MG without thymoma (MGTX; 2020 guidance); pathology thymic hyperplasia (synthetic). (5) Efgartigimod and complement inhibitors kept in reserve; the disease was not refractory. (6) Pneumocystis prophylaxis with trimethoprim-sulfamethoxazole while prednisone was 20 mg or more with azathioprine, a common practice threshold that the owner may review. (7) PCV20 and recombinant zoster vaccine before immunosuppression; inactivated vaccines only afterwards. MuSK antibodies and single-fiber EMG were not needed. The MG-ADL score has no LOINC code, so it is given in the notes.
  9. Kidney care. The documented hereditary polycystic kidney disease is staged synthetically: normal eGFR and urine albumin, kidneys enlarged with many cysts, height-adjusted total kidney volume 364 mL/m (Mayo Imaging Class 1B, not rapidly progressive), so tolvaptan is not indicated. Home blood pressure stayed below 130/85, so under KDIGO Practice Point 2.1.4 no medicine was started; the 110/75 target would apply if readings rose above 130/85, and a beta-blocker would be avoided because of MG. Water 2 to 3 liters a day, less salt, and no NSAIDs. No statement is made about which relatives had the disease.
  10. Culturally safe care. Laboratory work is arranged at a Cherokee Nation Health Services clinic near her home, with results shared; she is given time to understand each step; her own Cherokee medicine is respected, anchored to the documented help of Cherokee medicine people in her recovery, and no practice or ceremony is described; she is asked only to share any plant medicine so that interactions can be checked. Her words about “indigenous solutions to our problems” are quoted only as published. Nothing is claimed about Cherokee or Native patients in general.
  11. Protocol deviation. The blood count and liver tests due two, four and six weeks after azathioprine started were not done: the orders were placed at this clinic, she was preparing for surgery an hour's drive away, and no one followed up. The ten-week tests showed no toxicity, so no harm resulted. Corrective action: standing orders at the Cherokee Nation clinic near her home with a nurse call for each result (INT-011); the later checks were done on time.
  12. Synthetic clinical picture. Everything in the modern episode is synthetic: the symptoms, examination, every laboratory value, the antibody level, nerve stimulation, CT, ultrasound and DXA, the thymectomy and its pathology, the scores (PHQ-9, PHQ-2, MG-ADL, AUDIT-C), medicines and outcomes. Height (163 cm) and weights are synthetic. Reference ranges are typical adult female ranges.
  13. Preventive visit. A periodic adult preventive visit at 34 (CPT 99395 and 99497 in plain text), eleven weeks after thymectomy. Judgment calls: recombinant zoster dose 2 that day; influenza and COVID-19 at the seven-month visit; HIV and hepatitis C screening once; cervical screening shown as up to date (synthetic), with the interval to be reviewed on long-term immunosuppression; no live vaccines; HPV vaccine not wanted; contraception recorded only as “a reliable method, not recorded here”; advance care planning with an unnamed agent.
  14. Focused visits. The four chronic-care follow-ups (two weeks with the consultation, six weeks, five weeks after thymectomy, and seven months) are documented as focused visits on the 2016 and 2020 international MG guidance, KDIGO 2025 and ACR 2022. Synthetic findings introduced: MG-ADL falling from 7 to 1 (minimal manifestation status), FVC from 3.25 to 3.62 L, white cells rising on prednisone, a normal DXA, and hemoglobin A1c rising from 5.3 to 5.6 percent. The one deviation is the missed early azathioprine tests above.
  15. Consultation. The neuromuscular neurology referral and the consultation by Marcus Okafor-Delaney, MD (a fictional consultant), on the day of the second visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: generalized AChR antibody-positive MG without thymoma; pyridostigmine and prednisone started low and raised slowly; azathioprine after screening; early robotic thymectomy once stable; newer targeted therapies in reserve; and the crisis signs, medicines to avoid and kidney considerations.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-07-13
Progress note 04 (C-CDA)
Early azathioprine blood tests missedTwo, four and six weeks after startingNot done, a deviation from the protocol: the orders were placed here, she was preparing for surgery an hour's drive away, and no one followed up. Today's tests at ten weeks show no toxicity, so no harm resulted, but a low white count could have gone unnoticed. Corrective action: standing orders at the Cherokee Nation clinic near her home, with a nurse call for each result

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-03-23
Progress note 02 (C-CDA)
LaboratoryScreening before immunosuppression: hepatitis B, tuberculosis and TPMTOrderedDrawn today at the clinic
2026-03-23
Progress note 02 (C-CDA)
ReferralThoracic surgery for thymectomyOrderedAssessment visit in about four weeks
2026-08-24
Progress note 05 (C-CDA)
PreventionHIV screeningOrderedOnce for adults 15 to 65; no record of a test; drawn today
2026-08-24
Progress note 05 (C-CDA)
PreventionHepatitis C screeningOrderedOnce for adults 18 to 79; drawn today with the HIV test
2026-10-12
Progress note 06 (C-CDA)
ExaminationEye examination on glucocorticoidsOrderedBooked next month at the Cherokee Nation eye clinic

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

ClaimGradeStatement
CLM-0006DHer recovery was made harder by the emotional trauma of her friend's death in the crash.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-23Acetylcholine receptor binding antibody6.8 nmol/L (high)High
2026-05-04Glucose104 mg/dL (high)High